MYOM2 and hepatocellular carcinoma: The current study explores the potential of oncolytic therapy using GAS strains, with a particular focus on comparing the effects of the original S. pyogenes GUR strain and its M protein knockout mutant, S. pyogenes GURSA1, in syngeneic mouse models of hepatoma and pancreatic carcinoma.